Pete O'heeron
Chief Executive Officer at FibroBiologics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: FibroBiologics Inc., 2 years.
FibroBiologics Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
FibroBiologics Inc.
· Chief Executive Officer
Since January 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | FibroBiologics Inc. | Open-market purchase | +15,872 | $0.38 | $6,031 |
| Mar 3, 2026 | FibroBiologics Inc. | Open-market purchase | +18,200 | $0.41 | $7,462 |
| Mar 2, 2026 | FibroBiologics Inc. | Open-market purchase | +17,428 | $0.35 | $6,100 |
| Dec 9, 2024 | FibroBiologics Inc. | Gift | −100,000 | — | — |
| Dec 3, 2024 | FibroBiologics Inc. | Gift | −50,000 | — | — |
| Aug 12, 2024 | FibroBiologics Inc. | Open-market purchase | +8,500 | $1.91 | $16,235 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.